NanoString Technologies Receives Canadian Market Approval for its Prosigna Breast Cancer Prognostic Gene Signature Assay

[Business Wire] – NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that it has received a C more

View todays social media effects on NSTG

View the latest stocks trending across Twitter. Click to view dashboard

See who NanoString is hiring next, click here to view